Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma | Zendy

Ahmed O. Kaseb | Zendy; Jeffrey S. Morris | Zendy; Manal M. Hassan | Zendy; Adnan M. Siddiqui | Zendy; E. Lin | Zendy; Lianchun Xiao | Zendy; Eddie K. Abdalla | Zendy; JeanNicolas Vauthey | Zendy; Thomas A. Aloia | Zendy; Sunil Krishnan | Zendy; James L. Abbruzzese | Zendy

Open Access

Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma

Author(s) -

Ahmed O. Kaseb,

Jeffrey S. Morris,

Manal M. Hassan,

Adnan M. Siddiqui,

E. Lin,

Lianchun Xiao,

Eddie K. Abdalla,

JeanNicolas Vauthey,

Thomas A. Aloia,

Sunil Krishnan,

James L. Abbruzzese

Publication year - 2011

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2011.36.0636

Subject(s) - hepatocellular carcinoma , medicine , cirrhosis , vascular endothelial growth factor , proportional hazards model , oncology , gastroenterology , insulin like growth factor , survival analysis , carcinoma , growth factor , vegf receptors , receptor

Cirrhosis and hepatocellular carcinoma (HCC) together form a two-disease state that affects survival of patients with HCC and dictates treatment decisions and prognostic stratification of patients in clinical trials. The study objective was to improve prognostic stratification of patients with HCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research